Tradewinds Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8K Sell
224
-95
-30% -$11.1K 0.01% 280
2026
Q1
$38.4K Buy
319
+60
+23% +$6.93K 0.01% 249
2025
Q4
$27.3K Sell
259
-162
-38% -$15.2K 0.01% 275
2025
Q3
$35.3K Buy
421
+35
+9% +$2.88K 0.01% 244
2025
Q2
$30.6K Hold
386
0.01% 245
2025
Q1
$34.7K Sell
386
-11
-3% -$1.03K 0.01% 227
2024
Q4
$39.5K Buy
397
+11
+3% +$1.13K 0.01% 216
2024
Q3
$43.8K Hold
386
0.01% 195
2024
Q2
$47.8K Buy
386
+162
+72% +$20.9K 0.01% 181
2024
Q1
$29.6K Hold
224
0.01% 199
2023
Q4
$24.4K Hold
224
0.01% 177
2023
Q3
$23.1K Sell
224
-75
-25% -$8.08K 0.01% 172
2023
Q2
$34.5K Sell
299
-43
-13% -$4.88K 0.01% 145
2023
Q1
$36.4K Buy
342
+25
+8% +$2.7K 0.01% 139
2022
Q4
$35.2K Buy
317
+93
+42% +$9.51K 0.02% 126
2022
Q3
$19K Hold
224
0.01% 160
2022
Q2
$20K Sell
224
-2,919
-93% -$259K 0.01% 158
2022
Q1
$258K Sell
3,143
-23
-0.7% -$1.81K 0.04% 99
2021
Q4
$243K Buy
3,166
+50
+2% +$3.98K 0.04% 112
2021
Q3
$234K Sell
3,116
-84
-3% -$6.39K 0.04% 108
2021
Q2
$249K Sell
3,200
-39
-1% -$2.9K 0.05% 105
2021
Q1
$238K Buy
3,239
+140
+5% +$10.3K 0.05% 104
2020
Q4
$242K Hold
3,099
0.05% 103
2020
Q3
$245K Hold
3,099
0.06% 90
2020
Q2
$229K Sell
3,099
-880
-22% -$66.2K 0.06% 90
2020
Q1
$292K Buy
3,979
+1,297
+48% +$102K 0.09% 65
2019
Q4
$233K Buy
2,682
+518
+24% +$42.5K 0.07% 90
2019
Q3
$174K Buy
2,164
+39
+2% +$3.13K 0.07% 94
2019
Q2
$170K Sell
2,125
-372
-15% -$28.5K 0.07% 93
2019
Q1
$198K Sell
2,497
-158
-6% -$11.8K 0.07% 106
2018
Q4
$194K Sell
2,655
-1,104
-29% -$77.9K 0.1% 94
2018
Q3
$254K Buy
3,759
+6
+0.2% +$382 0.1% 91
2018
Q2
$217K Sell
3,753
-44
-1% -$2.48K 0.09% 101
2018
Q1
$197K Sell
3,797
-113
-3% -$6.1K 0.09% 104
2017
Q4
$210K Sell
3,910
-55
-1% -$3.05K 0.1% 99
2017
Q3
$242K Buy
3,965
+97
+3% +$5.88K 0.12% 90
2017
Q2
$237K Sell
3,868
-284
-7% -$17.3K 0.12% 88
2017
Q1
$252K Buy
4,152
+4
+0.1% +$243 0.16% 80
2016
Q4
$233K Sell
4,148
-133
-3% -$7.78K 0.15% 83
2016
Q3
$255K Buy
4,281
+44
+1% +$2.57K 0.18% 78
2016
Q2
$233K Sell
4,237
-214
-5% -$11.4K 0.17% 86
2016
Q1
$225K Sell
4,451
-43
-1% -$2.11K 0.15% 99
2015
Q4
$227K Buy
4,494
+30
+0.7% +$1.51K 0.16% 94
2015
Q3
$210K Sell
4,464
-33
-0.7% -$1.75K 0.16% 99
2015
Q2
$244K Buy
4,497
+78
+2% +$4.38K 0.17% 95
2015
Q1
$242K Buy
4,419
+3
+0.1% +$170 0.18% 94
2014
Q4
$239K Sell
4,416
-779
-15% -$43.4K 0.17% 97
2014
Q3
$294K Sell
5,195
-45
-0.9% -$2.53K 0.22% 77
2014
Q2
$289K Sell
5,240
-64
-1% -$3.49K 0.22% 80
2014
Q1
$287K Sell
5,304
-577
-10% -$29.9K 0.24% 79
2013
Q4
$281K Buy
+5,881
New +$269K 0.23% 76

Other funds holding MRK

Tradewinds Capital Management's MRK Position: Q2 2026 in Review

Tradewinds Capital Management reduced its Merck (MRK) stake by 30% in Q2 2026, selling an estimated $11.1K and leaving 224 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #280.

Tradewinds Capital Management first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $294K in Q3 2014. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tradewinds Capital Management held 224 shares of Merck worth $28.8K as of Q2 2026.
  • Tradewinds Capital Management sold 95 Merck shares in Q2 2026, an estimated $11.1K.
  • Merck made up 0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #280 holding.
  • Tradewinds Capital Management first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
  • Tradewinds Capital Management's Merck position peaked at $294K in Q3 2014.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.